Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.19, Iss.1, 2014-02, pp. : 10-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment Strategies in Myelodysplastic Syndromes

By Atallah Ehab Garcia-Manero Guillermo

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 208-216

Informa Healthcare

Access to resources Recommend Favorite

Hypomethylating agents for urologic cancers

By Alva Ajjai S Hahn Noah M Aparicio Ana M Singal Rakesh Yellapragada Sarvari Sonpavde Guru

Future Oncology, Vol. 7, Iss. 3, 2011-03 ,pp. : 447-463

Future Medicine

Access to resources Recommend Favorite

Biological Basis of Novel Therapies for Myelodysplastic Syndrome

Current Cancer Therapy Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 199-209

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

By Su Ying-Wen Chang Ming-Chih Chiang Ming-Fu Hsieh Ruey-Kuen

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Myelodysplastic Syndrome Transforming into Acute Myelogenous Leukemia with Azacytidine: A Retrospective Study from Cancer Centre in Northern India

By Suresh P.

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 3, 2010-09 ,pp. : 114-114

Springer Publishing Company

Access to resources Recommend Favorite